Activation of AKT-mediated pathway is well-documented for the soft tissue sarcomas and can be used as independent prognostic factor for tumor recurrence, overall survival (OS) and disease-free survival (DFS) [12,33,34]. This evidence concerns the gene AKT1 and soft tissue sarcoma.